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ABSTRACT
Nucleotide excision repair (NER) is the major DNA
repair process that removes diverse DNA lesions
including UV-induced photoproducts. There are
more than 20 proteins involved in NER. Among
them, XPC is thought to be one of the first proteins
to recognize DNA damage during global genomic
repair (GGR), a sub-pathway of NER. In order to
studythemechanismthroughwhichXPCparticipates
in GGR, we investigated the possible modifications
of XPC protein upon UV irradiation in mammalian
cells. Western blot analysis of cell lysates from
UV-irradiated normal human fibroblast, prepared by
direct boiling in an SDS lysis buffer, showed several
anti-XPC antibody-reactive bands with molecular
weighthigherthantheoriginalXPCprotein.Therecip-
rocal immunoprecipitation and siRNA transfection
analysis demonstrated that XPC protein is modified
by SUMO-1 and ubiquitin. By using several NER-
deficient cell lines, we found that DDB2 and XPA
are required for UV-induced XPC modifications.
Interestingly, both the inactivation of ubiquitylation
and the treatment of proteasome inhibitors quanti-
tatively inhibited the UV-induced XPC modifications.
Furthermore, XPC protein is degraded significantly
following UV irradiation in XP-A cells in which
sumoylation of XPC does not occur. Taken together,
we conclude that XPC protein is modified by SUMO-1
andubiquitinfollowingUVirradiationandthesemodi-
fications require the functions of DDB2 and XPA, as
wellastheubiquitin–proteasomesystem.Ourresults
also suggest that at least one function of UV-induced
XPC sumoylationisrelatedto thestabilizationofXPC
protein.
INTRODUCTION
Nucleotide excision repair (NER) is a versatile DNA repair
pathway toeliminate variousstructurally unrelated lesions that
distort the double helix, including UV light-induced cyclobu-
tane pyrimidine dimmers (CPDs) and pyrimidine (6-4)
pyrimindone photoproducts (6-4PP), as well as intrastrand
cross-links and bulky adducts induced by numerous chemical
compounds (1). NER has two distinct subpathways, global
genomicrepair(GGR)andtranscription-coupledrepair(TCR).
The former removes DNA lesions from the entire genome
whereas the latter only removes DNA damage from the tran-
scribed strands of transcriptionally active genes (2). Impaired
NER activity has been associated with several human genetic
disorders including Xeroderma Pigmentosum (XP), for which
seven NER-deﬁcient genetic complementation XP groups
(XP-A to -G) have been identiﬁed. Unlike most XP comple-
mentation groups, XP-C patients show a defect only in GGR
but TCR is normal. The gene defective in XP-C patients
encodes the XPC protein, which exists in vivo as a heterotri-
meric complex with hHR23B and centrin 2 (3–5). XPC-
hHR23B appears to function as a damage recognition factor
for GGR. Generally, XPC-hHR23B functions by recognizing
and binding structural abnormalities introduced into double-
stranded DNA by the lesions rather than recognizing any
structural characteristics of the lesions themselves (6,7). Con-
formational changes in DNA induced by XPC-hHR23B could
favor the subsequent binding of other NER factors such as
TFIIH, XPA, RPA and two NER endonucleases XPG and
ERCC1-XPF (6,8,9). Finally, the damage-containing oligo-
nucleotide is removed by dual incisions and the gap is ﬁlled
by DNA synthesis and ligation.
The changes of XPC protein levels during NER have been
suggested in several studies using mouse and human cells.
When XPC-GFP fusion protein was stably expressed in the
mHR23A/B DKO MEFs (double knock out mouse embryo
ﬁbroblasts) together with hHR23B, UV irradiation resulted
in dramatic accumulation of XPC-GFP (10). Compared to
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doi:10.1093/nar/gki684the exogenously expressed proteins, Okuda et al. (11) have
shown that endogenous mouse XPC is relatively stable, and
UVirradiationonlyinduced 10%increaseofXPClevelat9h
post-irradiation. However, experiments of Adimoolam and
Ford (12) demonstrated that human endogenous XPC protein
issigniﬁcantlyupregulated followingUVirradiationinseveral
human cells, and this response depends on the p53 status.
Furthermore, studies in Saccharomyces cerevisiae indicated
that the rapid degradation of ectopically expressed Rad4,
the yeast homologue of XPC, appeared to be mediated
by multi-ubiquitylation and DNA damage transiently stabil-
ized the overexpressed Rad4 (13). In both yeast and mamma-
lian systems, HR23B (in yeast, Rad23) has been shown to
function in NER by governing XPC stability via partial
protection against proteasomal degradation (10,13). However,
the ﬁnding of UV-induced modest accumulation of mXPC in
mHR23 / , as well as DKO cells indicates the existence of
additional mechanism for mXPC accumulation (e.g. the post-
translational modiﬁcation), for which the mHR23 proteins are
not necessary (11).
Small ubiquitin-related modiﬁer (SUMO) is the best-
characterized member of a growing family of ubiquitin-like
proteins involved in post-translational modiﬁcations (14–16).
In mammals, there are three members of the SUMO protein
family, SUMO-1, SUMO-2 and SUMO-3, which are implic-
ated in partly overlapping, yet distinct functions (17,18).
SUMO is covalently attached to other proteins through the
activities of an enzyme cascade similar to that for ubiquityla-
tion. There is only one known SUMO-activating enzyme, E1
and only one known SUMO-conjugating enzyme, E2 (Ubc9).
The functional consequences of the SUMO attachment vary
greatly from substrate to substrate, and in many cases,
such consequences are not understood at the molecular
level. Unlike ubiquitylation, sumoylation of proteins has not
been linked to protein degradation. Proposed functions for
sumoylation include regulation of protein–protein interaction
and localization, inhibition of ubiquitin-mediated degradation,
and regulation of transcription (16,19).
In the current study, we have shown that XPC protein
is modiﬁed covalently following UV irradiation. The recip-
rocal immunoprecipitation (IP) and RNA interference studies
demonstrated that UV-induced XPC modiﬁcations are both
SUMO-1 and ubiquitin conjugated. We also present evidence
suggesting that the UV-induced modiﬁcations of XPC are
related to several NER factors including DDB2 and XPA,
as well as ubiquitin–proteasome system.
MATERIALS AND METHODS
Cell culture and protein extraction
The normal human skin ﬁbroblasts (OSU-2), expressing
wild-type p53, were established and maintained in culture
as previously described (20). Li-Fraumeni Syndrome (LFS)
ﬁbroblast 041 cell line (p53-Null) was provided by Dr Michael
Tainsky (MD Anderson Cancer center, Austin, TX). Both cell
lines were grown in DMEM supplemented with 10% fetal calf
serum (FCS) and antibiotics at 37 C in a humidiﬁed atmo-
sphere of 5% CO2. The primary NER-deﬁcient ﬁbroblast cell
lines GM05509A (XP-A), GM15983(XP-C), GM01389A
(XP-E), GM04313E (XP-F) and GM03021B (XP-G) were
purchased from NIGMS Human Genetic Cell Repository
(Coriell Institute for Medical Research, Camden, NJ) and
were grown in MEM with 2· essential amino acid, 2· non-
essential amino acid and 2· vitamin supplemented with 15%
FCS and antibiotics. Human lung epithelial H460 cells and
XPA siRNA-expressing H460 cells [Achieved by infection
with a pRETRO-XPA retroviral vector encoding a hairpin-
forming siRNA speciﬁc to XPA (21)] were obtained from
Dr Anatoly Zhitkovich (Brown University, Providence, RI).
Mouse embryo ﬁbroblast ts20 (thermosensitive for E1
ubiquitin-activating enzyme) and its parental cell line A31N
were kindly provided by Dr Harvey L. Ozer (UMDNJ-New
Jersey Medical School). Both cell lines were cultured in 50%
F-10 + 50% DMEM medium containing 10% FCS and anti-
biotics at 32 C in a humidiﬁed atmosphere of 5% CO2 (22).
When needed, cells were transferred to the restrictive temper-
ature (39 C) 16 h prior to the treatment and beginning of the
experiments. UV irradiation was performed from a germicidal
lamp at a dose rate of 1.0 J/m
2/s as measured by a Kettering
model 65 radiometer (Cole palmer Instrument Co., Vernon
Hill, IL). At each time point, the cells were harvested and
the cell lysates were prepared by direct boiling in SDS lysis
buffer(62.5mMTris–HCl,pH6.8,10%glycerol,2%SDSand
protease inhibitors).
Antibodies and expression constructs
Anti-XPC antibody (XPC-2) was generated by immunizing
rabbits with the synthetic peptide (KTKREKKAAASHLFP-
FEKL) corresponding to the C-terminus of human XPC pro-
tein and afﬁnity-puriﬁed with the peptide (BioSource,
Hopkinton, MA). This antibody was found to recognize not
only the human but also the mouse XPC protein. Another
polyclonal anti-XPC antibody that is speciﬁc to the full length
of XPC protein was generously provided by Dr Fumio Hana-
oka (Osaka University, Japan). Anti-DDB2 antibody (DDB2-
A) was generated by immunizing rabbits with the synthetic
peptide (KRPETQKTSEIVLRPRNKR) corresponding to the
N-terminus of human DDB2 protein and afﬁnity-puriﬁed with
the peptide (BioSource). Polyclonal anti-XPA (FL-273), anti-
XPB (S-19), anti-SUMO-1 (FL-101), anti-Ubiquitin (FL-76),
anti-Lamin B (C-20), anti-Ubc9 (H-81) and monoclonal anti-
p53 (DO-1) antibodies were from Santa Cruz Biotechnology,
Inc (Santa Cruz, CA); rabbit anti-SUMO-2/3 was from Zymed
(South San Francisco, CA); monoclonal anti-Actin was from
Neomarkers (Fremont, CA); monoclonal anti-FLAG was from
Stratagene (La Jolla, CA); monoclonal anti-HA was from BD
Bioscience (San Jose, CA). The pcDNA3.1/XPC-V5-His and
the pcDNA3.1/XPA-V5-His expression constructs were
generated by respectively sub-cloning XPC and XPA cDNA
into pcDNA3.1/V5-His vector (Invitrogen, Carlsbad, CA).
The FLAG-tagged DDB2 construct (pBJ5-DDB2) was pro-
vided by Dr Gilbert Chu (Stanford University, Stanford,
CA). SUMO-FLAG was cut out from a pRK-based expression
vector for SUMO-FLAG (generously provided by Dr Xin-Hua
Feng, Baylor College of Medicine) with ClaI and HindIII,
and then sub-cloned into pcDNA3.1 vector (Invitrogen).
Wild-type p53 expression vector was kindly provided
by Dr Bert Vogelstein (Johns Hopkins University, Baltimore,
MD). The expression vector for Ub-HA was obtained
from Dr Dirk Bohmann (European Molecular Biology
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conducted with FuGene 6 (Roche, Indianapolis, IN) or
Lipofectamine 2000 (Invitrogen) according to the manufac-
turer’s instruction.
Immunoprecipitation and western blotting
IP was performed on the whole-cell lysates. The cell lysates
prepared by direct boiling in SDS lysis buffer were diluted
10-folds with RIPA buffer (50 mM Tris–HCl, pH 7.4, 1%
NP40, 0.25% Sodium Deoxycholate, 1 mM EDTA and
150 mM NaCl). Following preclearing with 30 ml of Protein
G plus/A agarose beads (Oncogene Research Products,
San Diego, CA), 2 mg of total protein was incubated with
desired antibodies overnight at 4 C, and then incubated
with 50 ml of Protein G plus/A agarose beads for another
1 h at 4 C. The beads were washed four times with
RIPA buffer, and then boiled in 2· SDS sample buffer. The
immunoprecipitates were then subjected to SDS–PAGE and
the speciﬁc proteins were detected by immunoblotting with
desired antibodies, as described earlier (23).
RNA interference
The target sequence of the Ubc9 siRNA was GCAGAG-
GCCTACACGATTTAC (Dharmacon Research, Lafayette,
CO), which corresponds to nucleotides 391–411 of the C-
terminus of human Ubc9 coding region. siRNA was transfec-
ted into OSU-2 cells using Lipofectamine 2000 (Invitrogen),
as described by the manufacturer’s instruction. Cells, after
48 h siRNA transfection, were UV irradiated at 20 J/m
2
and incubated for another 1 h. The cell lysates were prepared
by direct boiling in SDS lysis buffer and the same amount of
lysates were loaded onto a 4–12% gradient gel for SDS–PAGE
and western blotting.
RESULTS
UV treatment induces a series of novel covalent
modifications of XPC
Western blotting of UV-irradiated normal human ﬁbroblast
OSU-2 cell lysates, prepared by direct boiling in SDS lysis
buffer, revealed the existence of at least three protein species
cross-reacting withanXPC-speciﬁcpolyclonalantibody—one
oftheproteinsmigratingat125kDaandothersat145–220kDa
(Figure 1A). The predominant 125 kDa band is established to
represent endogenous XPC protein. However, the identity of
145–220 kDa proteins (discrete bands denoted by X, X0 and
X00), whose intensities are enhanced with the increased doses
of UV treatment, was obscure. In addition, our results showed
that the amount of 125 kDa XPC decreased following 1 h
of UV irradiation at the dose ranges from 5 to 50 J/m
2.I n
an extended time course experiment, the higher molecular
mass forms of XPC appeared within 5 min following 20 J/
m
2 UV treatment, reached the maximal level by 1 h and were
no longer detectable after 8 h (Figure 1B). The same UV
radiation-induced pattern of XPC variants was also detected
in extracts from several different human cell lines, e.g. HeLa,
WI38, HCT116 (data not shown) as well as in extracts of
mouse cells (see results below). Most importantly, these pro-
tein species as well as the endogenous XPC were not detected
in XP-C cells (data not shown) but could be detected in XP-C
cells ectopically expressing XPC-V5-His (see Results below),
further conﬁrming that 145–220 kDa proteins represented
altered variants of endogenous XPC.
Figure1.Multiplehigh-molecular-weightbandsofXPCresultedfromUVirradiationofnormalhumancells.OSU-2cellswereUVirradiatedat0,5,10,20and50J/
m
2andincubatedfor1h(A)orirradiatedat20J/m
2andincubatedforindicatedtimes(B).CelllysateswerepreparedbyboilinginSDSlysisbufferasdescribedinthe
Materials and Methods. Total protein (50 mg) was loaded for SDS–PAGE and detected by western blotting with rabbit anti-XPC antibody (XPC-2, 1:5000).
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Since the UV-induced high-molecular-weight forms of XPC
were detected under the denaturing condition (boiled in
SDS lysis buffer), we reason that XPC is modiﬁed covalently.
The common covalent modiﬁcations of proteins include phos-
phorylation, acetylation, ubiquitylation and sumoylation, etc.
Because the modiﬁed XPC has a high molecular-weight
which is at least 20 kDa more than that of native XPC, we
speculated that these modiﬁcations might be ubiquitylation or
sumoylation. In order to characterize such modiﬁcations, we
immunoprecipitated the lysates from both UV-treated and
mock-treated OSU-2 cells with anti-SUMO-1, anti-SUMO-
2/3 or anti-ubiquitin antibodies. The immunoprecipitates
were subjected to immunoblot analysis with rabbit anti-
XPC antibody. As shown in Figure 2A, no high-molecular-
weight form of XPC could be detected in the lysate from
mock-treated sample (lane 1), whereas the distinct high-
molecular-weightforms of XPC could be detected inthe lysate
from UV-treated sample (lane 5). Anti-SUMO-1, anti-SUMO-
2/3 and anti-ubiquitin antibodies did not pull down any
detectable XPC variant in mock-treated sample (lanes 2–4).
In contrast, these XPC variants were clearly detected in the
immunoprecipitates from anti-SUMO-1, but not anti-SUMO-
2/3 antibody in the UV-treated sample (lanes 6 and 7), indic-
ating that UV-induced covalent conjugates of XPC might be
SUMO-1. It seems that XPC is also modiﬁed by ubiquitin
following UV irradiation as we also detected a faint anti-
XPC reactive band (compared to lane 6) in the position of
modiﬁed XPC within the immunoprecipitates derived with
anti-ubiquitin antibody. To conﬁrm these results, we per-
formed a reciprocal IP experiment in which we immunore-
covered the XPC proteins from the lysates and detected the
SUMO-1 or ubiquitin conjugated proteins. Because our anti-
XPC antibody was deemed unsuitable for IP, we expressed
XPC protein tagged with V5 and His along with SUMO-1-
FLAG or ubiquitin-HA in XP-C cells and followed by UV
irradiation of transfected cells. The XPC protein was puriﬁed
with Ni-NTA agarose beads and detected by western blotting
with anti-XPC for XPC protein, anti-FLAG for sumoylated
XPC and anti-HA for ubiquitylated XPC. As shown in
Figure 2B, the modiﬁed XPC protein could be detected in
XP-C cells ectopically expressing XPC-V5-His following
UV irradiation (Figure 2B, lanes 1, 2, 5 and 6). In XP-C
cells transfected with both XPC and SUMO-1-FLAG, the
high-molecular weight band in the position of the modiﬁed
XPC could be detected by anti-FLAG antibody in UV-treated
Figure 2. UV-inducedhigh-molecular-weightbandsofXPCareSUMO-1conjugated(A)OSU-2cellswereUVirradiatedat20J/m
2andincubatedfor1h.Thecell
lysates were preparedby direct lysis in SDS lysis buffer and diluted in RIPA buffer as described in Materials and Methods.Total protein (2 mg)was subjected to IP
with anti-SUMO-1, anti-SUMO-2/3 or anti-Ubiquitin antibody. The precipitated proteins were detected by western blotting with anti-XPC antibody. Whole cell
lysates (50 mg) were loaded on SDS–PAGE as input. (B) XP-C cells were transfected with either XPC-V5-His plus SUMO-1-FLAG or XPC-V5-His plus Ub-HA,
thenUV irradiatedat20 J/m
2andallowedtorepairfor1h.Totalprotein(2mg)wasusedforpull-downwithNi-NTAagarosebeads.Theprecipitatedproteinswere
detected with anti-XPC, anti-FLAG or anti-HA antibody.
4026 Nucleic Acids Research, 2005, Vol. 33, No. 13but not mock-treated samples (Figure 2B, lanes 3 and 4).
Similarly, in XP-C cells transfected with both XPC and
ubiquitin-HA, the high-molecular weight bands in the position
of the modiﬁed XPC could also be detected by anti-HA anti-
body in UV-treated but not mock-treated samples (Figure 2B,
lanes 7 and 8). These results further conﬁrmed that XPC pro-
tein can be modiﬁed by both SUMO-1 and ubiquitin following
UV irradiation.
To further test whether one of the UV-induced XPC
modiﬁcations is a result of sumoylation, we sought to assess
the impact of disrupting the endogenous Ubc9 expression on
the UV-induced XPC modiﬁcation. Since Ubc9 is the only E2
enzyme formodiﬁcationbymembersofSUMOfamily,inhibi-
tion of its expression would disrupt sumoylation of its sub-
strates. We used a 21 nt siRNA that speciﬁcally targets to the
human Ubc9 coding region and examined its effectiveness in
silencing Ubc9 expression in OSU-2 cells as well as its inﬂu-
ence on UV-induced XPC modiﬁcation. After 48 h of trans-
fection with the siRNA, OSU-2 cells expressed a signiﬁcantly
lower level of Ubc9 protein (Figure 3, lanes 3, 4, 7 and 8). In
contrast, treatment of OSU-2 cells with unrelated control
siRNA did not reduce the level of Ubc9 protein (Figure 3,
lanes 2 and 6). As expected, no higher molecular-weight form
of XPC was detected in mock-treated OSU-2 cells, irrespect-
ive of the siRNA transfection. On the contrary, UV irradiation
indeedinduced the higher molecular-weight forms ofXPC and
the amount of modiﬁed forms of XPC decreased signiﬁcantly
in cells transfected with Ubc9 siRNA, but not control siRNA
(Figure 3, lanes 5–8). Relative inhibition measurement of
modiﬁed forms, compared with those from cells without trans-
fection, indicated  20 and 60% decrease in cells transfected
with 50and100nMUbc9siRNA,respectively(Figure3,lanes
7 and 8). These results further conﬁrmed that at least part of
UV-induced modiﬁcations of XPC is sumoylation. Interest-
ingly, transfection of Ubc9 siRNA also induced a decrease of
the XPC level following UV irradiation, with a 50% decrease
in cells transfected with 100 nM Ubc9 siRNA (Figure 3, lane
8 versus lane 5), indicating that Ubc9 acts as a stabilizer
of XPC protein following UV irradiation possibly through
conjugating SUMO to XPC protein.
DDB2 is required in UV-induced XPC modifications
Our studies, and others, have shown that DDB2 is a key factor
in regulating GGR of CPD, presumably through the recruit-
ment of XPC to the DNA damage sites (24–26). Moreover,
p53 could be participating in GGR via transactivating the
expression of DDB2 protein (27). Thus, we tested whether
DDB2 or p53 is involved in UV-induced XPC modiﬁcations.
Normal human ﬁbroblast OSU-2 cells, p53-deﬁcient 041 cells
and DDB2-deﬁcient XP-E cells were treated with 20 J/m
2 UV
and allowed to repair for 1 h. Western blot analysis of cell
lysates showed very weak modiﬁcations of XPC in 041 cells,
but no modiﬁcation in XP-E cells following UV irradiation
(Figure 4A, lanes 3–6), whereas such modiﬁcations were very
obvious in OSU-2 cells upon treatment with UV (Figure 4A,
lanes 1 and 2). It seems that both p53 and DDB2 are required
forUV-induced XPC modiﬁcation. To further attest thisresult,
we transfected p53 or DDB2cDNA into 041 cells to determine
whether the UV-induced XPC modiﬁcations could be visual-
ized upon restoration of these proteins. It is known that DDB2
deﬁciency in 041 cells is due to the lack of its upstream
transactivator p53 (27). Therefore, 041 cells with the ectop-
ically expressed DDB2 alone can be used to study the function
Figure 3. Ubc9siRNAknocksdowntheexpressionofUbc9andcompromisestheUV-inducedhigh-molecular-weightbandsofXPC.OSU-2cellsweretransiently
transfectedwitheithercontrolsiRNAorsiRNAtargetedtoUbc9for48h.ThecellswereUVirradiatedat20J/m
2andthenincubatedforanother1h.Thecelllysates
weresubjectedtoSDS–PAGEandproteinsdetectedbywesternblottingwithanti-XPC,anti-Ubc9oranti-Actinantibody.Theintensityofeachbandwasdetermined
by densitometry and the relative intensity of each band calculated in reference to control without transfection.
Nucleic Acids Research, 2005, Vol. 33, No. 13 4027of DDB2 without possible interference of p53. At 48 h
following transfection, the expression of p53 or DDB2 pro-
tein was conﬁrmed in the transfected 041 cells. As shown in
Figure 4B, 041 cells have undetectable level of p53 and DDB2
(lane 1). However, transfection of p53 not only restored the
expression of p53 but also increased the endogenous DDB2
level (lane 2). In contrast, transfection of DDB2 only restored
the expression of DDB2 while the p53 is still undetectable
(lane 3). Thus, these cell lines can be used to study the role
of p53 or DDB2 in UV-induced XPC modiﬁcation. As shown
in Figure 4C, the 041 cells transiently transfected with
p53 construct (p53+, DDB2+) showed the restoration of
UV-induced XPC modiﬁcations (Figure 4C, lane 6 versus
lane 4). Furthermore, the 041 cells transfected with DDB2
construct alone (p53 , DDB2+) also demonstrated the res-
toration of UV-induced XPC modiﬁcations (Figure 4C,
lane 8 versus lane 4). Thus, UV-induced sumoylation and
ubiquitylation of XPC appear to require normal DDB2 gene
product.
XPAisrequiredforUV-inducedmodificationsofXPCas
well as preventing UV-induced XPC degradation
It is well known that there are six core repair factors in GGR,
e.g. XPC-hHR23B,TFIIH, XPA,RPA, ERCC1-XPF and XPG
(28–31) and these factors are assembled sequentially at the
Figure 4. p53 and DDB2 are involved in UV-induced XPC modification by SUMO-1 and ubiquitin (A) OSU-2, p53-deficient 041 and DDB2-deficient XP-E cells
were UV irradiated at 20 J/m
2 and incubated for 1 h. The cell lysates were subjected to western blotting with anti-XPC antibody. (B) and (C) 041 cell lines were
transientlytransfectedwitheitherp53orDDB2-FLAGconstructfor48h.ThecellswereirradiatedwithUVat20J/m
2andrepairedfor1h.Thesegregatedproteins
were detected by western blotting with anti-p53 or anti-DDB2 to confirm the ectopic expression in transfectants (B). The XPC and its modifications were detected
with rabbit anti-XPC antibody (C).
4028 Nucleic Acids Research, 2005, Vol. 33, No. 13damage sites during the excision repair process (9). Amongst
them, XPA is considered as another damage recognition factor
to verify the damage and its recruitment to damage sites
requires XPC (6,9). ERCC1-XPF and XPG, two endonuc-
leases needed to incise the oligonucleotide containing damage
site, are recruited to the damage sites during the late steps.
In order to determine whether any of these relatively late
congregating factors are required for UV-induced XPC modi-
ﬁcations, we analyzed the XPC modiﬁcations in several cell
lines including XPA-deﬁcient XP-A cell line, XPF-deﬁcient
XP-F cell line and XPG-deﬁcient XP-G cell line. Western
blotting clearly showed that XPC modiﬁcation is not induced
upon UV irradiation in XP-A cells (Figure 5A, lane 4),
whereas a substantial amount of XPC modiﬁcation could be
Figure 5. UV-inducedXPCmodificationsarecompromisedinXP-Acells(A)OSU-2,XP-A,XP-FandXP-GcellswereUVirradiatedat20J/m
2andincubatedfor
another 1 h. The proteins were subjected to SDS–PAGE and detected with anti-XPC and anti-XPB (loading control) antibodies. (B) XP-A cells were transiently
transfectedwitheitheremptyvectororpcDNA3.1/XPAfor48h,UVirradiatedat20J/m
2andincubatedforanother1h.TheproteinsweresubjectedtoSDS–PAGE
anddetectedwithanti-XPC,anti-XPAandanti-Actin(loadingcontrol)antibodies.(C)H460cells,expressingeithercontrolvectororsiRNAtargetedto XPA,were
UVirradiatedat20J/m
2andincubatedforanother1h.Theproteinsweresubjectedto SDS–PAGEanddetectedwithanti-XPC,anti-XPAandanti-XPBantibodies.
Nucleic Acids Research, 2005, Vol. 33, No. 13 4029detected in XP-F cells following UV treatment (Figure 5A,
lane 6). In contrast, a very strong UV-induced signal of XPC
modiﬁcation, comparable to that seen in normal OSU-2 cells,
was detected in XP-G cells (Figure 5A, lane 8). Interestingly,
the steady-state level of XPC in XP-A cells decreased signi-
ﬁcantly upon UV irradiation (Figure 5A, lane 3 versus 4).
These results indicate that XPA is required for UV-induced
modiﬁcations of XPC, and it seems that more XPC protein is
degraded following UV irradiation in the absence of XPA
protein. To verify the involvement of XPA in UV-induced
XPC modiﬁcation, we transfected XPA cDNA into this XP-
A cells. As expected, the transfection restored not only the
expression of XPA but also UV-induced XPC modiﬁcations
in the XP-A cells (Figure 5B, lanes 3 and 4 versus lanes 1
and 2). Furthermore, the expression of XPA also reduced the
UV-induced XPC degradation. We further tested another pair
ofisogenicH460 celllines that are different onlyinthe expres-
sion level of XPA. H460 cells stably transfected with either
control vector or siRNA targeting to XPA were UV irradiated
at 20 J/m
2 and allowed to repair for 1 h. Western blotting with
anti-XPAantibody showedthatXPAproteinlevelisdecreased
signiﬁcantly in H460 cells with stably transfected XPA siRNA
(Figure 5C). Immunoblot analysis of XPC showed that the
amount of UV-induced XPC modiﬁcations was also reduced
in correspondence to the decreased XPA in this cell line
(Figure 5C). Meanwhile, the steady-state level of XPC was
seen to decrease slightly following UV irradiation in H460
cells expressing XPA siRNA, whereas no obvious change of
XPC level was observed in H460 cells with transfection of
control vector. These data further indicate that XPA is a key
determining factor in UV-induced modiﬁcations of XPC, and
XPA might be a stabilizer of XPC protein during NER.
Ubiquitin–proteasomesystemisrequiredinUV-induced
XPC modifications
We have shown that ubiquitin–proteasome system, affecting
XPC recruitment to the damage sites, is involved in NER
in mammalian cells (32). Here, we assessed whether the
ubiquitin–proteasome system is also involved in
UV-induced XPC modiﬁcations. We ﬁrst tested the role of
ubiquitylation in UV-induced XPC modiﬁcations by using a
mouse ts20 cell line that harbors a temperature-sensitive
ubiquitin-activating enzyme (E1). E1 ubiquitin-activating
enzyme is active at permissive temperature (32 C), whereas
inactive at restrictive temperature (39 C) and thereby com-
promising the ubiquitylation function. In the parent A31N
cells, UV irradiation was able to induce XPC modiﬁcations
at both 32 and 39 C, indicating that UV-induced XPC modi-
ﬁcations can also occur in mouse cells (Figure 6A, lanes 1–4).
Similarly, UV irradiation also causes XPC modiﬁcations in
ts20 cells cultured at 32 C, albeit the modiﬁcations are weaker
than that in A31N cells (Figure 6A, lane 6). In contrast, a very
signiﬁcant decrease of UV-induced XPC modiﬁcations could
be observed in ts20 cells cultured at 39 C (Figure 6A, lane 8).
These results suggest that ubiquitylation is involved in
UV-induced XPC modiﬁcations. We further examined the
involvement of 26S proteasome in UV-induced XPC modi-
ﬁcations by using the speciﬁc inhibitors of 20S catalytic
subunit, MG132 and lactacystin. Interestingly, the treatment
of OSU-2 cells with MG132 completely abolished the
UV-induced XPC modiﬁcations at different times following
UV irradiation (Figure 6B, lanes 3–8). Similarly, treatment
with another more speciﬁc 20S inhibitor, lactacystin, which
dramatically decreased the UV-induced XPC modiﬁcations
(Figure 6C, lane 4 versus lane 2) further strengthened the
participatory role of 26S proteasome in UV-induced XPC
modiﬁcation. Taken together, the results demonstrated that
ubiquitin–proteasome system is required for XPC modiﬁca-
tion following UV irradiation.
DISCUSSION
SUMO post-translationally modiﬁes many proteins with
demonstrated role in diverse processes including regulation
of transcription, chromatin structure and DNA repair [for
review, see (19)]. Many factors and enzymes associated
with DNA replication and repair including yeast PCNA, the
helicase WRN, Topoisomerases I and II, and the thymine-
DNA glycosylase enzyme, are post-translationally modiﬁed
by SUMO [for review, see (19,33)]. SUMO modiﬁcation
has been shown to regulate the subnuclear localization,
protein–protein interactions and activity of many factors
involved in maintenance of the genome. Ubiquitylation is
also believed to be involved in DNA repair, i.e. NER
(32,34–36). The NER factors DDB2 and Rad4 have been
reported to be ubiquitylated following UV irradiation
(13,37). Moreover, while this manuscript was under review,
Sugasawa et al. (38) reported that XPC protein, an initial
damage recognition factor in NER, is ubiquitylated upon
UV irradiation. In this study, we demonstrated that XPC pro-
tein is modiﬁed not only by ubiquitin, but also by SUMO-1
following UV irradiation. This discovery expands the sub-
strates of SUMO conjugation and for the ﬁrst time introduces
SUMO modiﬁcation in the phenomenon of NER. In addition,
we have also provided direct evidence for XPC ubiquitylation
in mammalian cells.
The role of various NER factors in the UV-induced
XPC sumoylation and ubiquitylation
While the results described herein provide the very clear
evidence for UV-induced XPC sumoylation and ubiquityla-
tion, we do not yet fully understand its signiﬁcance or role in
action mechanism. In our studies, we have shown that several
repair factors including DDB2 and XPA are required for
UV-induced XPC modiﬁcation. DDB2, as a subunit of
Damaged DNA binding complex (DDB), is thought to be
involved in NER [for review, see (39)], transcription, cell
cycle (40,41) and p53-mediated apoptosis on exposure to
UV radiation (42). During NER, DDB2 is believed to be
the very ﬁrst DNA damage recognition factor prior even to
XPC during the GGR of UV-induced CPD and is required for
XPC recruitment to DNA damage sites (24–26). Therefore, we
speculate that the role of DDB2 in UV-induced XPC modi-
ﬁcation is to help XPC recruitment and binding to the damage
sites, and thereafter enable its sumoylation and ubiquitylation.
Several studies have suggested that DDB2 is degraded through
ubiquitin-proteasome pathway following binding to the
damage sites (43,44). In the absence of ubiquitylation or
the degradation function of proteasome, DDB2 could not be
eliminated and the recruitment of XPC to damage sites will be
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efﬁciency (32). Thus, the basic prerequisite for XPC modi-
ﬁcation is that DDB2 would be initially recruited to the dam-
age sites, perhaps to open the local chromatin or distort the
local DNA structure, and then be degraded by ubiquitin–
proteasome pathway. Thereafter, XPC would be recruited to
those damage sites and allow the possibility of its modiﬁca-
tion. A plausible alternative that DDB2 itself might serve as a
SUMOligase forXPC sumoylationremainstobeinvestigated.
For instance, Sugasawa et al. (38) have shown that DDB2
exhibits E3 ligase activity, through a complex with DDB1,
Cullin 4A and Roc1, for XPC ubiquitylation. Whether this
complex can also sumoylate the interacting XPC protein
remains an open question.
It is recognized that DDB2 is not the only factor requiredfor
UV-induced XPC modiﬁcation. Our results showed that even
though XPC is localized at the damage sites, it would not be
modiﬁed in the absence of XPA. It is well known that the
assembly of NER factors at the damage sites is sequential and
XPC-hHR23B is the principal DNA damage binding protein
that is essential for the recruitment of other NER components
to the site of DNA damage. The recruitment of XPA to DNA
damage requires functional XPC whereas XPA is not needed
for the accumulation of XPC at sites of DNA damage (9).
However, Sugasawa et al. (38) results did not show any
involvement of XPA in UV-induced XPC modiﬁcation. The
apparent discrepancy between these two studies can, at pre-
sent, only be attributed to the use of different cellular systems.
First, two XP-A cell lines are from different individuals.
Second, the XP-A cells used in the present study are untrans-
formed, while that used by the Sugasawa et al. study is a SV40
transformed cell line. Like Sugasawa et al. we were also
unable to see the modiﬁcation response in XP12RO, another
SV40 transformed cell line (data not shown). We cannot rule
out the possibility that some XPA functionality is substituted
by other factors during the immobilization step. It may
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speciﬁc XPC antibody-cross-reacting bands than in untrans-
formed cell lines (38). Nevertheless, in this study, both the
XPA protein restoration experiment and XPA siRNA knock-
down experiment show that XPA is absolutely required for
UV-induced XPC modiﬁcation. Therefore, we posit that only
when XPA protein is recruited to the damage sites, does XPC
get modiﬁed.
The role of XPC sumoylation in NER
Based on the current understanding of the involved processes
and our results, it ispossible tospeculatethe functionalaspects
of XPC sumoylation. It has been shown that XPC and its yeast
homologue, Rad4, could be degraded through ubiquitin–
proteasome pathway (10,13). Our results have shown that
UV irradiation could trigger a slight degradation of XPC,
which occurs during the very early steps of NER, i.e. 1–2 h
following irradiation. However, the level of XPC protein
decreased signiﬁcantly following UV irradiation in cells
with little or no XPC sumoylation, e.g. XP-A cells, H460
cells expressing XPA siRNA, and OSU-2 cells transfected
with Ubc9 siRNA. It is already clear that one function of
SUMO modiﬁcation of target proteins is to stabilize them
by preventing their ubiquitylation via blockage of the lysine
residues where ubiquitin would normally attach to the protein
(45–48). Therefore, we reason that UV-induced XPC
sumoylation serves to inhibit its degradation. After leaving
from the NER complex, the XPC protein still remains func-
tionally active to initiate a new round of DNA damage recog-
nition. If, however, XPC is not modiﬁed, it will be degraded
via ubiquitin–proteasome system. A study in the yeast has
already shown that the level of Rad4 is very low in ubc9
knock out cells, indicating that Ubc9 functions in a path-
way to stabilize Rad4 possibly through conjugating SUMO
modiﬁcation (49).
The basal amount of XPC protein in the cells is clearly
important for the efﬁcient removal of UV-induced photo-
products. Emmert et al. (50) have shown that partially correc-
ted XP-C cells (with detectable but subnormal XPC protein
levels) had normal repair of CPD but minimal repair of 6-4PP.
Arecent study hasshownthatknockingoutbothmHR23Aand
mHR23B genes strongly reduced the steady-state levels of
XPC in MEFs which then exhibit the similar repair deﬁciency
as XP-C cells (10). Moreover, the ectopic expression of XPC
bypassed the repair defect of these cells. We also tried to
determine the role of UV-induced XPC sumoylation in the
NER by inhibiting this process through transfecting Ubc9
siRNA into the repair-proﬁcient OSU-2 cells. However, we
did not ﬁnd any difference in the removal of CPD and 6-4PP
between the transfected and untransfected cells (data not
shown). This can be explained by the fact that siRNA trans-
fection partially knocks down the levels of target protein and
the residual expression could be sufﬁcient for normal repair
function. As shown by results of Figure 3, Ubc9 siRNA
transfection inhibited 60% of the UV-induced sumoylation.
However, this level of SUMO modiﬁcation mediated inhibi-
tion caused the degradation of only 50% of cellular XPC. The
remaining XPC protein must have been sufﬁcient to undertake
a new round of damage recognition and, therefore, not detect-
ably affect repair. In contrast, however, the study in the yeast
has shown that the ubc9-1D strain (with deletion of Ubc9) had
low Rad4 levels and consequently increased UV sensitivity in
comparison to the normal strains (49). So, it is obvious that a
ﬁrm description of the function of UV-induced XPC sumoyla-
tion in the mammalian cells will have to await the develop-
ment of a new and more effective approach to eliminate
sumoylation.
Another recognized function of sumoylation is that SUMO
can alter substrate interaction with other macromolecules (16).
This effect of SUMO on biomolecular interactions also varies
for different substrates. For example, sumoylation allows Ran-
GAP1 to bind tightly to the nuclear pore complex protein
RanBP2/Nup358 (51,52), whereas SUMO-modiﬁed thymine-
DNA glycosylase showed a reduced afﬁnity for the DNA
substrate (53). Wakasugi and Sancar found that XPC-
hHR23B participates in the initial assembly of the excision
nuclease, but is then no longer present in the ultimate dual
incision complex (54). It is possible that soon after the factors
like TFIIH, XPA and/or RPA are gathered, the XPC-hHR23B
leaves the complex. As shown by the studies using the
cholesterol-derived lesion, the latter segment of the NER reac-
tion can, at least in vitro, be conducted without XPC (55).
Therefore, we reckon that one function of XPC sumoylation
might be to diminish the afﬁnity of the bound XPC molecules
to damaged sites and facilitate its leaving the NER complex
after accomplishing the recruitment of subsequent factors, e.g.
XPA and ERCC1-XPF. However, this hypothesis will have to
be substantiated through future experimentation.
The role of XPC ubiquitylation in NER
In this study, we also showed that XPC is ubiquitylated fol-
lowing UV irradiation in mammalian NER-proﬁcient cells.
Usually, the ubiquitylated proteins are targeted to the protea-
some for degradation (56). However, ubiquitylated proteins
are often known to serve a regulatory function independent of
proteolysis. Our results demonstrate an interesting phenom-
enon in which the repair-proﬁcient OSU-2 cells show a higher
level of UV-induced ubiquitylated XPC but lesser XPC
degradation than repair-deﬁcient XP-A cells following UV
irradiation. It seems that such UV-induced ubiquitylation of
XPC is not primarily for degradation, and that ubiquitylated
XPC destinedfor targeted degradation simplycannot be detec-
ted duetoitsrapidturnover.Sugasawaetal.alsofoundthatthe
UV-induced ubiquitylation of XPC did not induce degradation
via the 26S proteasome, and suggest that such ubiquitylation
alters the DNA binding properties of XPC which could have
affected the cell-free NER incision (38).
In summary, we have demonstrated that NER factor XPC
can be modiﬁed by SUMO-1 and ubiquitin following UV
irradiation. The modiﬁcation requires other functional NER
factors, including DDB2 and XPA. A critical interplay of the
ubiquitin–proteasome system affects the XPC modiﬁcation
and productive repair at the damage sites within the genome.
The function of UV-induced XPC sumoylation might be
related to the stabilization of XPC protein and the decreased
binding afﬁnity of XPC to damaged DNA. Future work
entails the mapping of the sumoylation sites within
the XPC protein and clariﬁcation of the precise functional
role of XPC sumoylation and ubiquitylation in the regulation
of NER.
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